Search - tctmd.com

Displaying 41 - 60 of 1203

Sort: Relevancy | Date

Presentation TCT 2025

TCT 190: Optical Coherence Tomography Outcomes in Patients with In-stent Restenosis Treated with Drug-Eluting Stent vs Drug-Coated Balloon

Presenter: Hang Long Li

October 26, 2025

Presentation TCT 2025

TCT 186: Management of In-Stent Restenosis in Coronary Vein Grafts: Revascularization Strategies and Outcomes

Presenter: Oludamilola Akinmolayemi

October 26, 2025

Presentation TCT 2025

Sirolimus-Eluting Balloon Versus Repeat Drug-Eluting Stenting or Balloon Angioplasty for In-stent Restenosis

Presenter: Donald Cutlip

October 26, 2025

Presentation TCT 2025

TCT 185: The Incidence of In-Stent Restenosis Among Patients with Cancer

Presenter: Akram Mahdi

October 26, 2025

Presentation TCT 2025

TCT 184: Impact of Intravascular Imaging on Clinical Outcomes in Patients with In-Stent Restenosis: A Single-Centre Observational Study

Presenter: Nihit Shah

October 26, 2025

Presentation TCT 2025

TCT 189: Follow-up of Flow-Reserve-Guided Treatment for In-Stent Restenosis of Drug-Eluting Coronary Stents

Presenter: Kornel Kakonyi

October 26, 2025

Presentation TCT 2025

TCT 179: In-Stent Restenosis in Chronic Kidney Failure: Long-Term Outcomes Following Drug-Coated Balloons Versus Thin-Strut Drug-Eluting Stents

Presenter: Rafal Adam Januszek

October 26, 2025

Presentation TCT 2025

TCT 180: Paclitaxel-Coated Balloon versus Uncoated Balloon for Coronary In-Stent Restenosis in Patients with Acute Coronary Syndromes: A Subanalysis of the AGENT IDE Trial

Presenter: Neal S. Kleiman

October 26, 2025

Presentation TCT 2025

TCT 182: Impact of Lesion Preparation Strategy on the Efficacy of Paclitaxel Coated Balloon for Coronary In-stent Restenosis: A Subgroup Analysis of the AGENT IDE Randomized Trial

Presenter: Aditya Mantha

October 26, 2025

Presentation TCT 2025

TCT 181: Efficacy and Safety of Coronary Angioplasty Using a Paclitaxel-Coated vs Uncoated Balloon in Patients with In-Stent Restenosis Stratified by Restenosis Risk: A Subanalysis of the AGENT IDE

Presenter: Prakriti Gaba

October 26, 2025

Presentation TCT 2025

TCT 175: Contemporary Trends for the Treatment of In-Stent Restenosis in the United States: Insights from the CathPCI Registry

Presenter: Jennifer Rymer

October 26, 2025

Presentation TCT 2025

TCT 174: A Comparative Analysis of Clinical Outcomes in Patients with In-Stent Restenosis Undergoing Percutaneous Coronary Intervention with Drug Coated Balloons and Drug Eluting Stents

Presenter: Haseeb Ur Rahman

October 26, 2025

Presentation TCT 2025

TCT 172: Outcomes of Radiation Overlap and Margin Length in Intracoronary Brachytherapy for In-Stent Restenosis

Presenter: Chloe Kharsa

October 26, 2025

Presentation TCT 2025

TCT 173: Sex-Based Differences in Long-Term Outcomes Following Intravascular Brachytherapy for In-Stent Restenosis

Presenter: Mangesh Kritya

October 26, 2025

Presentation TCT 2025

TCT 334: Investigating the Safety and Efficacy of HydroDynamic Contrast Recanalization in In-Stent Restenosis-Related Coronary Chronic Total Occlusions

Presenter: Akshitha Yarrabothula

October 26, 2025

Presentation TCT 2025

TCT 176: Mid-Term Outcomes of PCI in In-Stent Restenosis versus De-Novo Lesions in an Urban Center with a Large African American Population: An Updated Retrospective Analysis

Presenter: Ankit Hanmandlu

October 26, 2025

Presentation TCT 2025

TCT 177: Procedural Success of Excimer Laser Coronary Angioplasty in the Setting of In-stent Restenosis: Meta Analyses

Presenter: Jasvindar Singh

October 26, 2025

Presentation TCT 2025

A Novel Drug-Eluting Retrievable Scaffold for Coronary In-Stent Restenosis (Reflow Medical): Early First in Human Results

Presenter: Scott Harding

October 26, 2025

Presentation TCT 2025

Everolimus-Coated Balloon Intervention for Patients with In-Stent Restenosis: 3-Year Clinical Results

Presenter: Fernando Alfonso

October 26, 2025

Presentation TCT 2025

TCT 324: In-Stent Restenosis Rates in CTO-PCI: a Call for a Hybrid Approach

Presenter: Stephane G. Carlier

October 26, 2025

Advertisement

TCT 190: Optical Coherence Tomography Outcomes in Patients with In-stent Restenosis Treated with Drug-Eluting Stent vs Drug-Coated Balloon

TCT 186: Management of In-Stent Restenosis in Coronary Vein Grafts: Revascularization Strategies and Outcomes

Sirolimus-Eluting Balloon Versus Repeat Drug-Eluting Stenting or Balloon Angioplasty for In-stent Restenosis

TCT 185: The Incidence of In-Stent Restenosis Among Patients with Cancer

TCT 184: Impact of Intravascular Imaging on Clinical Outcomes in Patients with In-Stent Restenosis: A Single-Centre Observational Study

TCT 189: Follow-up of Flow-Reserve-Guided Treatment for In-Stent Restenosis of Drug-Eluting Coronary Stents

TCT 179: In-Stent Restenosis in Chronic Kidney Failure: Long-Term Outcomes Following Drug-Coated Balloons Versus Thin-Strut Drug-Eluting Stents

TCT 180: Paclitaxel-Coated Balloon versus Uncoated Balloon for Coronary In-Stent Restenosis in Patients with Acute Coronary Syndromes: A Subanalysis of the AGENT IDE Trial

TCT 182: Impact of Lesion Preparation Strategy on the Efficacy of Paclitaxel Coated Balloon for Coronary In-stent Restenosis: A Subgroup Analysis of the AGENT IDE Randomized Trial

TCT 181: Efficacy and Safety of Coronary Angioplasty Using a Paclitaxel-Coated vs Uncoated Balloon in Patients with In-Stent Restenosis Stratified by Restenosis Risk: A Subanalysis of the AGENT IDE

TCT 175: Contemporary Trends for the Treatment of In-Stent Restenosis in the United States: Insights from the CathPCI Registry

TCT 174: A Comparative Analysis of Clinical Outcomes in Patients with In-Stent Restenosis Undergoing Percutaneous Coronary Intervention with Drug Coated Balloons and Drug Eluting Stents

TCT 172: Outcomes of Radiation Overlap and Margin Length in Intracoronary Brachytherapy for In-Stent Restenosis

TCT 173: Sex-Based Differences in Long-Term Outcomes Following Intravascular Brachytherapy for In-Stent Restenosis

TCT 334: Investigating the Safety and Efficacy of HydroDynamic Contrast Recanalization in In-Stent Restenosis-Related Coronary Chronic Total Occlusions

TCT 176: Mid-Term Outcomes of PCI in In-Stent Restenosis versus De-Novo Lesions in an Urban Center with a Large African American Population: An Updated Retrospective Analysis

TCT 177: Procedural Success of Excimer Laser Coronary Angioplasty in the Setting of In-stent Restenosis: Meta Analyses

A Novel Drug-Eluting Retrievable Scaffold for Coronary In-Stent Restenosis (Reflow Medical): Early First in Human Results

Everolimus-Coated Balloon Intervention for Patients with In-Stent Restenosis: 3-Year Clinical Results

TCT 324: In-Stent Restenosis Rates in CTO-PCI: a Call for a Hybrid Approach

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content